ES8502430A1 - Procedimiento para preparar derivados de 4-oxo-tiazolidin-2-iliden-acetamida. - Google Patents

Procedimiento para preparar derivados de 4-oxo-tiazolidin-2-iliden-acetamida.

Info

Publication number
ES8502430A1
ES8502430A1 ES532322A ES532322A ES8502430A1 ES 8502430 A1 ES8502430 A1 ES 8502430A1 ES 532322 A ES532322 A ES 532322A ES 532322 A ES532322 A ES 532322A ES 8502430 A1 ES8502430 A1 ES 8502430A1
Authority
ES
Spain
Prior art keywords
preparation
nervous system
central nervous
yliden
thiazolidin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES532322A
Other languages
English (en)
Spanish (es)
Other versions
ES532322A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Goedecke GmbH
Original Assignee
Goedecke GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Goedecke GmbH filed Critical Goedecke GmbH
Publication of ES532322A0 publication Critical patent/ES532322A0/es
Publication of ES8502430A1 publication Critical patent/ES8502430A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/34—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cephalosporin Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Pyrrole Compounds (AREA)
ES532322A 1983-05-10 1984-05-09 Procedimiento para preparar derivados de 4-oxo-tiazolidin-2-iliden-acetamida. Expired ES8502430A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3317000A DE3317000C2 (de) 1983-05-10 1983-05-10 4-Oxo-thiazolidin-2-yliden-acetamid-derivate, Verfahren zu deren Herstellung und deren Verwendung bei der Bekämpfung von durch das Zentralnervensystem bedingten Konvulsionen

Publications (2)

Publication Number Publication Date
ES532322A0 ES532322A0 (es) 1985-01-01
ES8502430A1 true ES8502430A1 (es) 1985-01-01

Family

ID=6198604

Family Applications (2)

Application Number Title Priority Date Filing Date
ES532322A Expired ES8502430A1 (es) 1983-05-10 1984-05-09 Procedimiento para preparar derivados de 4-oxo-tiazolidin-2-iliden-acetamida.
ES532331A Granted ES532331A0 (es) 1983-05-10 1984-05-09 Procedimiento para preparar derivados de 4-oxo-tiazolidin-2-iliden-acetamida

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES532331A Granted ES532331A0 (es) 1983-05-10 1984-05-09 Procedimiento para preparar derivados de 4-oxo-tiazolidin-2-iliden-acetamida

Country Status (19)

Country Link
US (1) US4563471A (forum.php)
EP (1) EP0124911B1 (forum.php)
JP (1) JPS59206372A (forum.php)
AT (1) ATE65778T1 (forum.php)
AU (1) AU565799B2 (forum.php)
BG (2) BG40143A3 (forum.php)
CA (1) CA1237436A (forum.php)
CS (1) CS244814B2 (forum.php)
DD (1) DD224319A5 (forum.php)
DE (2) DE3317000C2 (forum.php)
DK (1) DK162048C (forum.php)
ES (2) ES8502430A1 (forum.php)
GR (1) GR82086B (forum.php)
HU (1) HU190566B (forum.php)
IE (1) IE57372B1 (forum.php)
PL (2) PL142365B1 (forum.php)
SU (2) SU1251803A3 (forum.php)
YU (2) YU45183B (forum.php)
ZA (1) ZA843489B (forum.php)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0269024A3 (en) * 1986-11-21 1990-05-09 Godecke Aktiengesellschaft Use of 3-methyl-4-oxothiazolidin-2-ylidene-acetamide derivatives in the treatment of aids
ES2092539T3 (es) * 1991-01-10 1996-12-01 Transcend Therapeutics Inc Uso de derivados de la tiazolidina-4-carboxilato para el tratamiento de enfermedades pulmonares.
US5747459A (en) * 1991-02-04 1998-05-05 Nestec, Ltd. Method for insuring adequate intracellular glutathione in tissue
US5430045A (en) * 1992-04-23 1995-07-04 Free Radical Sciences, Inc. Method of reducing or preventing bone marrow hypoplasia
US6133299A (en) * 1993-02-25 2000-10-17 Warner-Lambert Company Methods for treating neurodegenerative diseases and disorders using N-(2,6-disubstituted aromatic)-N'-pyridinyl ureas and other anticonvulsant compounds
US5447712A (en) * 1993-12-09 1995-09-05 Free Radical Sciences Method of reducing cyclophosphamide induced hemorrhagic cystitis
KR100329808B1 (ko) * 2000-01-14 2002-03-25 박호군 2-펜아실리덴-3,5-알킬치환된-1,3-티아졸리딘-4-온의 효율적 제조 방법

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1150985B (de) * 1961-03-06 1963-07-04 Warner Lambert Pharmaceutical Verfahren zur Herstellung von Thiazolidin-4-on-Derivaten
FR2726M (fr) * 1962-12-04 1964-08-17 Warner Lambert Pharmaceutical Amides de thiazolidinones substituées.
DE2423725C2 (de) * 1974-05-16 1982-12-30 Gödecke AG, 1000 Berlin 5-Phenyl-4-oxo-Delta 2,ALPHA-thiazolidinessigsäureester

Also Published As

Publication number Publication date
HU190566B (en) 1986-09-29
ES532322A0 (es) 1985-01-01
ATE65778T1 (de) 1991-08-15
DE3317000A1 (de) 1984-11-15
JPS6316386B2 (forum.php) 1988-04-08
DK229984A (da) 1984-11-11
IE57372B1 (en) 1992-08-12
DE3484859D1 (de) 1991-09-05
CS244814B2 (en) 1986-08-14
YU79284A (forum.php) 1986-10-31
EP0124911B1 (de) 1991-07-31
HUT34174A (en) 1985-02-28
PL252100A1 (en) 1985-11-05
DK162048B (da) 1991-09-09
AU565799B2 (en) 1987-10-01
CA1237436A (en) 1988-05-31
DK229984D0 (da) 1984-05-09
ES8502696A1 (es) 1985-01-16
EP0124911A3 (en) 1987-02-04
ZA843489B (en) 1984-12-24
SU1251803A3 (ru) 1986-08-15
SU1272985A3 (ru) 1986-11-23
DK162048C (da) 1992-02-10
BG40143A3 (en) 1986-10-15
DE3317000C2 (de) 1986-09-25
YU63586A (en) 1986-10-31
PL142398B1 (en) 1987-10-31
PL142365B1 (en) 1987-10-31
JPS59206372A (ja) 1984-11-22
PL247581A1 (en) 1985-07-16
AU2788984A (en) 1984-11-15
GR82086B (forum.php) 1984-12-13
EP0124911A2 (de) 1984-11-14
ES532331A0 (es) 1985-01-16
IE841150L (en) 1984-11-10
DD224319A5 (de) 1985-07-03
US4563471A (en) 1986-01-07
BG41129A3 (en) 1987-04-15
YU45183B (en) 1992-05-28

Similar Documents

Publication Publication Date Title
IL61708A0 (en) Platinum(iv)diamine-complexes,a process for the preparation thereof,process for the preparation of a medicine using such a platinum(iv)-diamine-complex for the treatment of ccancer as well as the shaped medicine thus obtained
HUT42324A (en) Process for producing pharmaceutical compositions containing metoprolole
UA29450C2 (uk) Похідні гідроксамової кислоти, спосіб їх одержання, спосіб впливу на хвороби та фармацевтична або ветеринарна композиція, що їх містить
HUT36116A (en) Process for producing n,n-piperazinyl- derivatives and pharmaceutical compositions containing them
HUT39061A (en) Process for production of haploids, bihaploids and homozigota-plants from these substances
DE3571982D1 (en) Benzisoselenazolethiones,process for their preparation and pharmaceutical products containing these compounds
HUT51485A (en) Process for production of immune-hindering, monoquin, especially internuclein-1-hindering medical compositions
IL86061A (en) Derivatives of trans-3,4-isomer of 4-methyl-4-phenyl-piperidines,process for their preparation and pharmaceutical compositions containing them
HUT46857A (en) Process for producing pharmaceutical compositions for treating bone-hurts
HUT36119A (en) Process for production of pirido-4,3-g-indole derivatives and medical preparatives consisting of such compounds
HUT47123A (en) Process for producing phosphorous compounds and pharmaceutical compositions comprising them as active ingredient, as well as their intermediates
ES8607916A1 (es) Un procedimiento para la preparacion de medicamentos influenciadores de la circulacion sanguinea, que contienen compuestos de bis (carboxamida)
ES8502696A1 (es) Procedimiento para preparar derivados de 4-oxo-tiazolidin-2-iliden-acetamida
DE3466395D1 (en) Dipeptides of l-5-hydroxy-tryptophane, process for their preparation and medicaments containing them
EP0267297A4 (en) SIALOSYLCHOLESTEROL, PROCESS FOR THE PREPARATION AND MEDICINE AGAINST DISORDERS OF THE NERVOUS SYSTEM.
DE3164719D1 (en) Drugs with cytostatic activity, derivatives of isocyanuric acid and process for their preparation
ATE137237T1 (de) R-(-)-1-(5-hydroxyhexyl)-3-methyl-7- propylxanthin, verfahren zu dessen herstellung und diese verbindung enthaltende arzneimittel
IL134039A0 (en) Polyhydroxybutylpyrazines, their preparation and medicines containing them
HUT64548A (en) Method for producing new phosphocipid derivatives and pharmaceutical preparatives containing them
MY8600467A (en) 3,3-dialkyl-and 3,3-alkylene-indoline derivatives, process for their production and pharmaceutical compositions comprising them
ES8800198A1 (es) Procedimiento para preparar derivados de acidos aziridin-2- carboxilicos substituidos en n
HU9201306D0 (en) Process for the production of medical preparations for treating anxiety, containing r/+/-3-amino-1-hydroxy-pyrolydin-2-on
ZA817559B (en) 1-carboxy-azaalkanoylindoline-2-carboxylic acids,process for their manufacture,pharmaceutical preparations containing these compounds and their therapeutic application
ZA801969B (en) 2-aminoalkyl-5-pyridinols,process for their manufacture,pharmaceutical preparations containing these compounds and their therapeutic application
ATE94558T1 (de) Sialosylcholesterol, verfahren zu dessen herstellung und arzneimittel zur behandlung von krankheiten des nervensystems.

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20000601